Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
108,8 INR | +0,65% |
|
+2,45% | -12,61% |
Vakgebied
Aantal werknemers: 296
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Formulations
91,9
%
| 1 754 | 90,4 % | 855 | 91,9 % | -51,25% |
Bulk Drugs
3,0
%
| 82 | 4,2 % | 28 | 3,0 % | -65,50% |
Processing Charges
2,4
%
| 79 | 4,1 % | 23 | 2,4 % | -71,36% |
Commission
1,1
%
| 17 | 0,9 % | 10 | 1,1 % | -40,22% |
Royalty
0,7
%
| 4 | 0,2 % | 6 | 0,7 % | +70,39% |
Export Incentives
0,5
%
| 5 | 0,3 % | 4 | 0,5 % | -13,61% |
Other Operating Income
0,4
%
| 0 | 0,0 % | 4 | 0,4 % | +4.940,00% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Rest of World
52,8
%
| 535 | 29,2 % | 466 | 52,8 % | -12,95% |
India
47,2
%
| 1 300 | 70,8 % | 417 | 47,2 % | -67,91% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 37 | 01-04-10 | |
Director of Finance/CFO | 63 | 01-07-14 | |
Kishore P. Shah
CMP | Compliance Officer | - | 09-11-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 76 | 08-08-22 | |
Chairman | 73 | 08-08-23 | |
Director of Finance/CFO | 63 | 01-07-14 | |
Chief Executive Officer | 37 | 01-04-10 | |
Dhara P. Shah
BRD | Director/Board Member | 36 | 04-08-21 |
Shashil Mendonsa
BRD | Director/Board Member | - | 08-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 35 690 000 | 14 386 677 ( 40,31 %) | 0 | 40,31 % |
Bedrijfsgegevens
Lyka Labs Ltd.
Ground Floor, Spencer Building 30, Forjett Street
400036, Mumbai
+91 22 6611 2200
http://www.lykalabs.com![Adres Lyka Labs Limited(LYKALABS)](https://cdn.zonebourse.com/static/address/46728637.png)
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Lyka BDR International Ltd.
![]() Lyka BDR International Ltd. Pharmaceuticals: MajorHealth Technology Lyka BDR International Ltd. manufactures and markets finished pharmaceutical formulations and ready-to-fill lyophilized sterile active pharmaceutical ingredients products. It markets formulations in various dosage forms. The firm also sells human and veterinary products in Sudan. The company was founded on July 19, 1993 and is headquartered in Mumbai, India. |
Pharmaceuticals: Major
|
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,96% | 630 mld. | |
-7,15% | 350 mld. | |
+18,77% | 328 mld. | |
+8,79% | 298 mld. | |
+18,02% | 246 mld. | |
+1,27% | 225 mld. | |
+11,95% | 218 mld. | |
+3,68% | 160 mld. | |
-4,38% | 156 mld. |
- Beurs
- Aandelen
- Koers LYKALABS
- Koers LYKALABS
- Onderneming Lyka Labs Limited